Search PubMed⌕ Search

Biomedical subjects

S Albrecht

Publications and source records attributed to S Albrecht.

At least 145 records · Page 8Linked to original sources

Nucleolar organizer regions in superficial spreading melanoma with nodule.

Nucleolar organizer regions (NORs) are genes coding for the ribosomal RNA; they also induce the formation of the nucleolus at interphase. Transcriptionally active NORs can be visualized in histological sections with a silver colloid method, allowing direct counting of these structures (so-called AgNORs). Seven superficial spreading melanomas with nodule (i.e., melanomas containing both a radial and a vertical growth phase) were studied with the technique. The nuclear AgNOR counts (mean +/- SEM) were 5.44 +/- 1.70 for the radial growth phase and 7.65 +/- 2.35 for the vertical growth phase (P less than 0.01). This difference in mean nuclear AgNOR numbers may be related to other known differences in the biological behavior of the two growth phases.

Aged↗

[The application of peroxyoxalate-chemiluminescence in biochemical analysis: determination of oxalate].

A new sensitive method for the determination of oxalate is presented. By using the chemiluminescence decay of monoperoxyoxalic acid very low concentrations of oxalate can be determined (up to 100 nmol/l). Oxalate determinations in urine require the precipitation of calcium oxalate, in order to avoid oxalate-unspecific side emissions. This could be avoided by combination with a specific enzymatic partial reaction, which would also permit the determination of low concentrations of other organic species (e.g. citrate, pyruvate, malate).

Luminescent Measurements↗

Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome.

Focal nodular hyperplasia (FNH) is a lesion of the liver in which a large anomalous artery is located within a region of hyperplastic hepatic parenchyma. Patients with FNH commonly have other lesions, often vascular in nature, in the liver or other organs. We have noted that these associated lesions almost always occur in patients with multiple FNH. We therefore studied 27 autopsied patients with FNH. All 13 with multiple FNH had other lesions such as hemangioma of liver, meningioma, astrocytoma, telangiectasis of the brain, berry aneurysm, dysplastic systemic arteries, and portal vein atresia. One patient had several of these lesions including multiple FNH, meningioma, astrocytoma, vascular malformation of the brain stem, and hemangioma of the liver. In contrast, among the 14 patients with solitary FNH there were no associated lesions, except for hepatic hemangioma in one patient. The prevalence of this syndrome was estimated by examination of 2500 serial autopsies and autopsies with various components of the syndrome. On review of 73 consecutive autopsies with meningioma, three had multiple FNH, compared with seven of 2500 consecutive adult autopsies (P less than 0.001). Multiple FNH was found in two of 83 autopsies with astrocytoma (P less than 0.05) and in one of 139 autopsies with berry aneurysm (not significant). We describe a telangiectatic subtype of FNH which occurs in this syndrome as well as in a minority of patients with solitary FNH. The existence and character of this syndrome suggest that there may be an underlying systemic abnormality in some patients having components of the syndrome. Investigation of patients with multiple FNH lesions may reveal significant treatable lesions.

Adolescent↗

Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: a prospective randomized study.

In a prospective randomized trial we evaluated the influence of the calcium antagonist diltiazem (Dil) on the development of acute tubular necrosis (ATN) in cadaveric kidney transplantation. Dil was added to Eurocollin's solution (20 mg/l) at donor nephrectomy. The graft recipient received a preoperative bolus injection of Dil (0.28 mg/kg) which was followed by an infusion of Dil (0.0022 mg/min/kg) for 2 days. Thereafter, Dil was applied orally. Immunosuppressive therapy consisted of ciclosporin (CS) and low-dose steroids. There were no significant differences between the groups with respect to donor characteristics, HLA matching and ischemic periods. In the control group (n = 22), 9 patients (41%) developed ATN compared to 2 patients (10%) in the Dil group (p less than 0.05). In the control group, 3.5 +/- 0.4 HD per patient were necessary compared to 0.6 +/- 0.2 in the Dil group (p less than 0.05). Although CS blood levels were significantly higher in the Dil group (1st week 1,150 vs. 728 ng/ml; p less than 0.01), the GFR of grafts with primary function was significantly higher in the Dil group (day 7:39 vs. 24 ml/min; p less than 0.05). A significant reduction of the CS dose by 30% (p less than 0.01) led to comparable CS levels. In the Dil group, significantly fewer rejection episodes occurred during the first month. Our data indicate that the application of the calcium antagonist Dil lowered the incidence of posttransplant ATN. In addition, there is a possibility that Dil not only ameliorates ischemic damage in the kidney, but also reduces CS nephrotoxicity.

Acute Kidney Injury↗

[Protective effect of the calcium antagonist diltiazem on acute kidney failure following kidney transplantation. The results of a prospective randomized study].

UNLABELLED: In a prospective randomised study the effect of the calcium antagonist diltiazem on primary transplant failure following cadaver kidney transplantation was studied. The transplants were perfused with a solution containing 20 mg/l diltiazem, the graft recipient received diltiazem as a bolus injection of 0.28 mg/kg pre-operatively, followed by a continuous infusion of 0.0022 mg/kg X min for 48 hours. Thereafter diltiazem was applied orally (twice 60 mg/d). Glomerular filtration rate and renal blood flow were measured by single-shot techniques (inulin, PAH). For immunosuppression ciclosporin A and low-dose methylprednisolone were given. Nine patients (41%) in the control group (n = 22) but only two (10%) in the diltiazem group (n = 20) developed primary transplant failure (P less than 0.05). Glomerular filtration rate in transplants with primary function was significantly higher in the diltiazem group (day 4: 29 +/- 0.8 vs. 20 +/- 0.8; day 7: 39 +/- 1.4 vs. 24.9 +/- 0.7 ml/min, P less than 0.05) although ciclosporin blood levels were significantly higher in this group (week 1: 1150 vs. 728 ng/ml, P less than 0.01). The rate of rejection episodes was significantly higher in controls than in patients on diltiazem (0.5 +/- 0.05 vs. 0.1 +/- 0.02 rejection episodes per patient in the first postoperative month, P less than 0.05). CONCLUSION: Diltiazem has a protective effect against primary transplant failure following cadaver kidney transplantation. Furthermore, it might reduce the nephrotoxicity of ciclosporin A.

Acute Kidney Injury↗

[Organ preserving spleen surgery in childhood].

Our experiences with organ saving procedures of the spleen in childhood are presented. In 9 out of 12 children (75%) with traumatic rupture we preserved the organ partially or completely. In 4 patients a partial splenectomy was performed, in three cases of splenorrhaphy was done, and once the organ was repaired with fibrin adhesive. One child was treated conservatively. Another patient underwent splenectomy followed by autotransplantation. Two out of twelve died intra- or postoperatively from severe concomitant injuries. Out of 11 patients with Hodgkin's disease we performed partial splenectomy in five. Only in macroscopically involved cases the organ was removed. In one patient a huge epidermoid cyst of the spleen was enucleated. In another child with a big twisted wandering spleen a splenopexy after partial resection was carried out. In children the spleen should be preserved if ever possible.

Adolescent↗

A team approach to nursing research.

The study of the relationship of handedness to the laterality of breast cancer in women is intriguing. Results may affect facets of breast cancer diagnosis and therapy. Maybe not in same way as the discovery of the relationship of high oxygen concentrations to the development of blindness in premature infants, but the study may identify women at higher risk and provide new insights to scientists studying the pathophysiology of breast oncogenesis. It is the belief of the authors that laterality research is one of the fields that could easily lend itself to investigation by large numbers of nurses in hospitals across the country if a national organization became involved in it. If nursing is to be successful in its quest for recognition as one of the professions making a serious contribution to theory, it must mobilize its forces. Nursing, recognized as the largest single health profession in the United States, has great potential for accomplishment if the talent of every member of the profession is recognized and utilized in efforts to build up the science of nursing.

Adult↗

Higher frequency of left-breast cancer: a possible explanation.

A study of 1027 women with unilateral breast cancer showed that ipsilateral breast cancer was more common before age 45 and contralateral thereafter. The data suggest a possible explanation of the higher incidence of left-breast cancer in American women. A higher percentage of left-handed women developed breast cancer before age 45, but the over-all incidence of unilateral breast cancer was not greater in left-handed women than in right-handed or ambihanded subjects.

Adult↗

[Lymphocyte reactivity against fetal antigens during the growth and regression of experimental tumors].

Sensitization of lymphocytes occurs to fetal antigens during growth of malignant tumours. Sensitization was measured by the MEM-technique. Antigenic preparations, obtained by extraction with 3 M KCl of mouse fetal tissues were used. Growing tumors after allogenic transplantation of tumour cells gave rise to cellular sensitization. The disappearance of the tumours resulted in a decrease of the sensitization status. Lymphocytic sensitization to fetal antigens was evident in mice with intradermally growing tumors, too. After ligation, followed by regression of the tumours the sensitization became no longer detectable. The results show that tumour regression is associated with reversibility of cellular sensitization to fetal antigens.

Animals↗

[Lymphocyte reactivity of tumor-bearing mice to a 3M KCl extract of fetal mouse tissue: removal of diffusion chambers containing tumor cells reverses the reactivity].

Sensitization of lymphocytes to 3M KCl fetal extracts was shown by the MEM test after diffusion chambers containing tumor cells have been implanted into mice. Lymphocyte reactivity was still present 2, 4 and 6 weeks after removal of the chambers. When tested after 9 and 12 weeks the sensitization was no longer detectable. This results show the reversibility of sensitization after complete removal of tumor cells.

Animals↗

Lymphocyte reactivity in normal and malignant cell proliferation against a phylogenetically conserved antigen in fetal extracts.

Lymphocyte reactivity to 3-M KCl extracts from fetuses of different species of origin was shown by the macrophage electrophoretic mobility (MEMB) and/or the leukocyte migration inhibition tests in tumor-bearing mice and humans. In chemical carcinogenesis, reactivity was detectable before tumors developed. Six weeks after sc injection of 1,000 micrograms benzo[a]pyrene [(BP) CAS: 50-32-8] into XVII/Bln mice, the MEMB test became positive. The latent period was 15 weeks after 1.0 micrograms BP, indicating a dose-response relationship of the phenomenon. Painting of mouse skin with 7,12-dimethylbenz[a]anthracene [(DMBA) CAS: 57-97-6], croton oil (CAS: 8001-28-3), or benzene (CAS: 71-43-2) had the same sensitizing effect as BP. In contrast to the strong carcinogens BP and DMBA that caused lymphocyte reactivity to persist until tumors developed, benzene and the promoter croton oil induced only a transient effect. Termination of treatment abolished reactivity within 12 weeks. Lymphocyte reactivity to fetal extract in normal cell proliferation was evident from the fact that two-thirds-hepatectomized rats and BCG-treated mice became MEMB-positive. In hepatectomized rats the effect was reversible according to the completion of liver regeneration. Lymphocytes from tumor-bearing mice reacted with mouse and human fetal extract as well as with extracts from different developmental stages of frogs and fish. Fetal extracts were assumed to contain a phylogenetically conserved antigen.

Animals↗

[Detection of cellular sensitization in mice after treatment with chemical carcinogens].

Mice were treated epicutaneously (DMBA, benzene) and subcutaneously (BP, MNH) with chemical carcinogens. As detected by the MEM-test a cellular sensitization developed against fetal antigens, which are present in 3M KCl-extracts of mouse fetal tissue. The sensitization was detected before formation of tumors occurred. The conclusion was drawn that sensitization to fetal antigens is not a characteristic feature of tumor-bearing animals.

9,10-Dimethyl-1,2-benzanthracene↗

[Cellular sensitization to fetal antigens during chemical carcinogenesis].

Tumor-bearing mice show a cellular sensitization to fetal antigens as detected by the macrophage electrophoretic mobility (MEM) test. Sensitization is independent of etiological and histological tumor factors. An identical state of sensitization can be found after application of chemical carcinogens (N-methyl-N-nitrosourea, benz(a)pyrene or 7,12-dimethylbenz(a)anthracene) before the tumors have developed. The results indicate that the effect is dose-dependent.

Animals↗

Reactivity in neoplasia, preneoplasia, and pregnancy of lymphocytes against fetal extracts: cross-reactions between man and mouse.

KCl extracts (3 M) from human fetuses were tested by macrophage electrophoretic mobility (MEMB), leukocyte migration inhibition, and/or leukocyte adherence inhibition techniques against lymphocytes-leukocytes from tumor-bearing humans and control persons. A positive MEMB test was found in 209 of 284 (73%) patients with various types of clinically manifest tumors. Only 15 of 134 (11%) controls gave a positive reaction by the MEMB test. Leukocyte migration was significantly inhibited in 48 of 64 (75%) tumor patients, and leukocyte adherence was significantly inhibited in 40 of 50 (80%) tumor patients versus 7 of 50 (14%) and 10 of 54 (19%) in the corresponding controls. Lymphocyte reactivity to fetal extracts is also detectable in inbred XVII/Bln, CBA/Bln, and C3H/Bln mice bearing spontaneous or transplanted tumors of different etiology. Human and mouse fetal extracts gave cross-reactions. Lymphocytes from tumor-bearing mice were reactive against fetal extracts from the cow, pig, sheep, guinea pig, cat, and chicken. Mice bearing benign skin warts induced by 7,12-dimethylbenz[a]anthracene (DMBA) as well as DMBA-treated mice without visible skin lesions gave a positive MEMB test. Likewise, pregnancy is associated with lymphocyte reactivity to fetal extracts.

Animals↗

The leukocyte adherence inhibition test in tumor patients using 3M KCl extracts of fetal tissues as antigens.

The sensitization of tumor patients was evaluated with the LAI test to 3M KCl extracts of human fetuses derived from abortion in the 1st-3rd month, 5th month and 7th month of pregnancy. Positive responses were seen against preparations from fetuses at different developmental stages: reactivity was found among 12/18 (1st-3rd month), 13/15 (5th month) and 14/16 (7th month) of the tumor patients. In total, 80% (39/49) of the patients were sensitized to fetal extracts. In contrast, only 19% (10/54) of the control group reacted positively in the LAI test.

Antigens↗

Cellular sensitization in man and mice during pregnancy to fetal antigens as detected by lympholine assays.

Soluble extracts were prepared by the 3 M KC1 method from human mouse fetuses at different stages of development. As shown by macrophage electrophoretic mobility and by leukocyte migration inhibition tests a high percentage of pregnant women is sensitized to components of these extracts. The testing of pregnant mice of an inbred strain gave similar results. The available data support the view that some kind of cellular sensitization to fetal antigen may occur during pregnancy.

Animals↗